Noxopharm: A wonder drug?
Listen to ASX-listed Noxopharm CEO Dr Graham Kelly talk to Matt Birney on the Bulls N’ Bears Report about Noxopharm’s very scalable universal drug technology that could potentially be used on almost any cancer.
You can now log in once to listen live, watch live, join competitions, enjoy exclusive 6PR content and other benefits.
You will soon need to register to keep streaming 6PR online. Register an account or skip for now to do it later.
Listen to ASX-listed Noxopharm CEO Dr Graham Kelly talk to Matt Birney on the Bulls N’ Bears Report about Noxopharm’s very scalable universal drug technology that could potentially be used on almost any cancer.